LifeMD (LFMD) Liabilities and Shareholders Equity (2012 - 2025)

LifeMD's Liabilities and Shareholders Equity history runs 14 years deep, the most recent figure standing at $70.4 million for Q4 2025.

• Quarterly Liabilities and Shareholders Equity fell 7.47% year-over-year to $70.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283.6 million (up 3.52% YoY) and the FY2025 annual result came in at $70.4 million, down 7.47% from the prior year.
• Liabilities and Shareholders Equity was $70.4 million for Q4 2025 at LifeMD, up from $66.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $76.1 million in Q4 2024 and bottomed at $16.4 million in Q3 2021.
• A 5-year average of $47.9 million and a median of $45.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity jumped 718.13% — and 2022, when it plunged 48.59%.
• LifeMD's Liabilities and Shareholders Equity stood at $49.9 million in 2021, then plunged by 48.59% to $25.7 million in 2022, then soared by 127.85% to $58.5 million in 2023, then soared by 30.12% to $76.1 million in 2024, then declined by 7.47% to $70.4 million in 2025.
• Business Quant data shows LFMD's Liabilities and Shareholders Equity at $70.4 million in Q4 2025, $66.0 million in Q3 2025, and $73.6 million in Q2 2025.